Q3 2026 Earnings Call February 5, 2026 5:00 PM ESTCompany ParticipantsJason Starr - Head of Investor RelationVincent Pilette ...

“By dividing and conquering…we’re seeing responses in multiple different subtypes of sarcoma…and moving toward more of an individualized therapy that we try to design for every patient, where we take ...

Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...

AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today reported positive data in a year-end update from the ongoing Phase 2 clinical study ...

Detailed price information for Rogers Sugar Inc (RSI-T) from The Globe and Mail including charting and trades.

Reynolds Consumer Products Inc. (NASDAQ:REYN) Q4 2025 Earnings Call Transcript February 4, 2026 Reynolds Consumer Products ...

W.W. Grainger, Inc. (NYSE:GWW) Q4 2025 Earnings Call Transcript February 3, 2026 W.W. Grainger, Inc. misses on earnings ...

In this article we explore the latest developments in UK and EU Sustainability and ESG regulation in financial services, including ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it will be ...

Reduce abandonment, increase AOV, and scale checkout reliability with UX, payments, performance, and testing best practices.